结合IgA1和Streptococcus mutans表面表达的原结合蛋白,有助于IgA脏病发病的发生
Daiki Matsuoka1, Kana Suehara1, Shuhei Naka1
1Department of Pediatric Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan.
Frontiers in cellular and infection microbiology
|January 23, 2026
概括
突变性 estreptococcus 的原结合蛋白 (Cnm) 与免疫球蛋白 A1 (IgA1) 相结合. 这种相互作用可能会导致IgA脏病 (IgAN) 通过导致IgA1沉积在脏.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 突变性流杆菌是一种与各种感染有关的细菌.
- 原结合蛋白 (Cnm) 是 Streptococcus mutans. 的一种表面蛋白质.
- 免疫球蛋白A (IgA) 在粘膜免疫中起作用,可能与脏疾病有关.
研究的目的:
- 为了研究Streptococcus mutans Cnm和人类IGA之间的相互作用.
- 确定这种相互作用是否有助于IgA脏病 (IgAN) 的发展.
主要方法:
- 酶相关免疫吸收试验 (ELISA) 用于测试Cnm与人体免疫球蛋白的结合.
- 鼠类炎模型被用于评估Cnm局部化 in vivo.
主要成果:
- 与其他细菌表面蛋白相比,IgA1对Cnm的结合亲和力显著更高.
- 与其他免疫球蛋白类别相比,Cnm对IgA1的结合明显更强.
- 在大鼠中,Cnm的使用导致IgA沉积在淋巴细胞中区域,并与Cnm结合.
结论:
- 来自Streptococcus mutans的Cnm特别与IgA1.1结合在一起.
- 这种结合相互作用被认为有助于IgA1在球体中的沉积.
- Cnm-IgA1复合体可能在IgA瘤病变的发病过程中发挥作用.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K
The Equilibrium Binding Constant and Binding Strength
10.0K
10.0K
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Nuclear Binding Energy
14.7K
The difference between the calculated and experimentally measured masses is known as the mass defect of the atom. In the case of helium-4, the mass defect indicates a “loss” in mass of 4.0331 amu – 4.0026 amu = 0.0305 amu. The loss in mass accompanying the formation of an atom from protons, neutrons, and electrons is due to the conversion of that mass into energy that is evolved as the atom forms. The nuclear binding energy is the energy produced when the atoms’ nucleons are bound...
14.7K


